Corewell Health West
Trial Pipeline
Vascular Trial Associated Registry Pilot
NCT07076082
Roux-en-Y Gastric Bypass Versus Loop Gastrojejunostomy for Malignant Gastric Outlet Obstruction
NCT05986890
Effect of Hernia Sac Excision on Crural Tension in Paraesophageal Hernia Repair
NCT07197619
Intra-Corporeal Anastomosis Result in Quicker Return of Bowel Function/Earlier Discharge
NCT03862781
Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases
NCT03856658
Impact of Virtual Reality on Pre-procedural anxieTy Prior to Heart cathEterIzAtion - VR-THEIA
NCT03662607
Prophylactic Maze to Prevent Atrial Fibrillation in Adult Cardiac Surgery
NCT03604432
Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.
NCT02777775
Pilot Study to Assess the Use of Spy Elite for Assessment of Amputation Healing
NCT02440295
Phase I: Melphalan, Bendamustine and Carfilzomib for Autologous Transplant in Multiple Myeloma
NCT02148913
TAP Versus Thoracic Epidural in Major Abdominal Resections
NCT02197988
Gut Microbial Transplantation in Pediatric Inflammatory Bowel Diseases
NCT01560819
The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children
NCT00913497
RCT for Intermittent Versus Continuous Propofol Sedation for Pediatric Brain and Spine MRI Studies
NCT00515359
An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy
NCT00467922
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
| Phase 3 | 1 |
| Phase 4 | 2 |
What the Pipeline for Corewell Health West Shows
According to the ClinicalTrials.gov registry, Corewell Health West is linked to 15 US clinical trials across every stage of research activity. Of those, 4 studies are currently recruiting — about 27% of the sponsor's indexed portfolio — and 9 are already marked complete, representing roughly 60% of the total. Recruiting share is one of the more practical signals here: it reflects how much of a sponsor's research is presently open to new participants, while the completed share indicates the depth of finished work that has already contributed registry results. Both counts come directly from the public ClinicalTrials.gov dataset and are refreshed on the registry side; this page mirrors the latest data pull without altering it.
The phase mix for Corewell Health West reports 3 late-stage studies (Phase 3 and Phase 4 combined) and 3 earlier-phase studies (Phase 1 and Phase 2). A portfolio weighted toward Phase 3 usually reflects an organization advancing candidates toward regulatory review, where the research centers on comparative efficacy and broader safety across larger populations. A heavier Phase 1 and Phase 2 tilt generally indicates exploratory work — safety, dosing, and early signal detection — and is common among research-forward sponsors that seed many early programs. Phase 4 entries, when present, track interventions already in real-world use and typically focus on long-term safety, effectiveness across subgroups, or formulation comparisons.
The top therapeutic focus area indexed for Corewell Health West is Cord Tethering or Malformation with 1 linked trial, and 9 other condition areas appear in the top list above. That distribution is a quick read of where the organization concentrates its research attention; it does not imply product availability, market share, or any clinical endorsement. All numbers on this page come from ClinicalTrials.gov maintained by the National Library of Medicine, and counts can shift as new studies are registered or existing ones update their status. This information is provided for reference and educational purposes only, not as medical, investment, or regulatory advice — verify current details directly with ClinicalTrials.gov before relying on any figure here.
Read our methodology — how this data is sourced, computed, and verified.